论文部分内容阅读
９４例初菌阴肺结核，随机分入甲（实验）１ＨＲＺ／２Ｈ＿３Ｒ＿３、乙（对照）１ＨＲＺ／３Ｈ＿３Ｒ＿３二组。病例采用全程管理下服药。疗程结束时。痰涂片及痰培养均未有阳性发现；Ｘ线明显吸收率分别为４２．０％、４５．５％。二组间无显著性差异（Ｐ＞０．０５）。随访一年，二组均未有菌阳发现；Ｘ线甲组恶化２例（４％），乙组恶化１例（２．２％）二组间无显著性差异（Ｐ＞０．０５）。
94 cases of primary bacilli and pulmonary tuberculosis were randomly divided into two groups (experimental) 1HRZ / 2H_3R_3 and B (control) 1HRZ / 3H_3R_3. Cases under the full management of medication. End of treatment. No sputum smear and sputum culture were found positive; X ray obvious absorption rates were 42.0%, 45.5%. There was no significant difference between the two groups (P> 0.05). One year after follow-up, there was no positive bacterium in both groups. There was no significant difference between the two groups (P> 0.05) in 2 cases (4%) in group A, 2 cases in group B (2.2% .